4 assetsChina-origin programs → US partnersAgreements since 2023
Phase 3 3Phase 2 1Current global phase · China-origin includes overseas subsidiaries · Selected assets
EGFR / HER3 · ADCPhase 3
BL-B01D1
izalontamab brengitecan
LicensorSystImmuneBiokin parent · China
US partner
Current developmentChina · TNBC, ESCC, NPC
AgreementDec 2023
Nectin-4 · ADCPhase 3
CRB-701
SYS6002
LicensorCSPC MegalithCSPC group · China
US partner
Current developmentChina · cervical cancer
AgreementFeb 2023
DLL3 · ADCPhase 2*
SHR-4849
IDE849
LicensorHengrui PharmaChina
US partner
Current developmentMonotherapy · Phase 1/2 program
AgreementDec 2024
TROP2 / HER3 · ADCPhase 3
JSKN016
TROP2 × HER3 ADC
LicensorJiangsu AlphamabChina
US partnerPathosAI
Current developmentTNBC
AgreementAug 2026
*IDE849: monotherapy is labelled Phase 2 within a Phase 1/2 study; combinations are Phase 1.
Phases & territories
| Asset | Announced | Phase at announcement | Current phase · geography | Rights |
|---|---|---|---|---|
| BL-B01D1 / izalontamab brengitecan | 2023-12-11 | Global Phase 1; China phase unspecified | Phase 3 in China: TNBC, ESCC and nasopharyngeal carcinoma | US co-development/co-commercialization; BMS exclusive rest-of-world rights outside mainland China |
| CRB-701 / SYS6002 | Feb 2023 · license month | China Phase 1 in 2023; signing-day phase unspecified | China: Phase 3 cervical; Phase 2 mUC. US/EU: Phase 2/3 pending. | US, Canada, EU/EFTA, UK and Australia |
| SHR-4849 / IDE849 | 2024-12-29 | Phase 1 | Monotherapy: Phase 2*; combinations: Phase 1 | Outside Greater China |
| JSKN016 | 2026-08-03 | Phase 3 TNBC; earlier-phase studies also ongoing | Phase 3 · TNBC | Outside mainland China, Hong Kong, Macau and Taiwan |
Dates show announcements or disclosed license months.
CLI query
Deal → drug → developer · China-based developer/seller filter
python3 -m gosset.cli deals \
--deal-type Licensing \
--since 2023-01-01 \
--where drug.modality=ADC \
--where drug.developer.country=China \
--where drug.phase=2,3 \
--where seller.country=China \
--where 'buyer.country=United States' \
--all --include-ids --debug